Novavax, Inc. (NVAX) Appoints John J. Trizzino As Senior Vice President, Commercial Operations
3/10/2014 9:53:47 AM
GAITHERSBURG, Md., March 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the appointment of John J. Trizzino to the position of Senior Vice President, Commercial Operations, effective March 10, 2014. Mr. Trizzino will be responsible for developing and implementing the commercialization strategy in support of the company's product candidates, including its RSV F, quadrivalent seasonal and pandemic influenza vaccine candidates.
Help employers find you! Check out all the jobs and post your resume.
comments powered by